174 related articles for article (PubMed ID: 4090451)
1. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
[No Abstract] [Full Text] [Related]
2. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
Traissac FJ; Borg R
Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
[No Abstract] [Full Text] [Related]
3. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic diseases of the liver with catergen].
Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
[TBL] [Abstract][Full Text] [Related]
5. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
Sov Med; 1985; (12):26-30. PubMed ID: 4095626
[No Abstract] [Full Text] [Related]
6. [Effect of carsil and legalon in treating chronic liver diseases].
Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
[TBL] [Abstract][Full Text] [Related]
7. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
Machalke K; Müller B
Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
[No Abstract] [Full Text] [Related]
8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
[No Abstract] [Full Text] [Related]
9. [Treatment of chronic hepatitis patients with catergen].
Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
Reutter FW; Haase W
Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
[No Abstract] [Full Text] [Related]
11. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
[TBL] [Abstract][Full Text] [Related]
12. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
Realini S; Gonvers JJ; Hofstetter JR
Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
[No Abstract] [Full Text] [Related]
13. [Thiomesterone and liver function].
Pickert H
Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
[No Abstract] [Full Text] [Related]
14. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
[No Abstract] [Full Text] [Related]
15. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
Abonyi M; Kisfaludy S; Szalay F
Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
[TBL] [Abstract][Full Text] [Related]
16. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
[No Abstract] [Full Text] [Related]
17. [Glucocorticoids in chronic liver diseases].
Maier KP; Talke H; Gerok W
Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
[No Abstract] [Full Text] [Related]
18. [Clinical experimentation with Aïcamine in hepatic insufficiency].
Négret JP
Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
[No Abstract] [Full Text] [Related]
19. Effects of (+)-cyanidanol-3 on chronic liver injury.
Kovách G; Salamon F
Acta Physiol Hung; 1984; 64(3-4):443-8. PubMed ID: 6152368
[TBL] [Abstract][Full Text] [Related]
20. [What is certain in the therapy of hepatocellular diseases with cyanidanol?].
Schomerus H
Internist (Berl); 1983 Dec; 24(12):684-9. PubMed ID: 6363332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
